BB's Stock Haven

[Edward]

Since 12/24/2024 CTOR IS UP 30.3% AND UP 13% IN THE FIRST 2 TRADING DAYS OF 2025.

Newly approved cancer treatment by the FDA set for initial sales in the 1st QUARTER OF 2025.

This is CTOR's first and only product currently.

CTOR has a small float of appox. 5.9 million shares ( see (A) below:

The market cap is appox. $93 million.

( A) CTOR has 71,552,402 shares O/S a/o 9/30/2024, whereas CTXR owns 92.2%.